Shuichi Sakamoto
Chairman chez Asahi Kasei Pharma Corp.
Profil
Shuichi Sakamoto is currently the Chairman at Asahi Kasei Pharma Corp.
He previously worked as a Director at Asahi Kasei Corp.
from 2016 to 2019.
Postes actifs de Shuichi Sakamoto
| Sociétés | Poste | Début |
|---|---|---|
Asahi Kasei Pharma Corp.
 Asahi Kasei Pharma Corp. Investment ManagersFinance Part of Asahi Kasei Corp., Asahi Kasei Pharma Corp. is a pharmaceutical and diagnostic company based in Tokyo, Japan. Asahi Kasei Pharma operates in the healthcare business unit of the Asahi Kasei Group, with a mission to sincerely care for each individual life and solve their unmet medical needs with a wealth of ideas and solid science. Asahi Kasei Corp. is a US $20 billion Japanese technology company that provides innovative, science-based solutions to a diverse range of markets including healthcare, chemicals and fibers, housing and construction materials, and electronics. Founded in 2003, the private company has developed innovative drugs in the fields of orthopedics, acute care, neurology (including pain), and immunology. | Chairman | 01/04/2018 |
Anciens postes connus de Shuichi Sakamoto
| Sociétés | Poste | Fin |
|---|---|---|
| ASAHI KASEI CORPORATION | Director/Board Member | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ASAHI KASEI CORPORATION | Process Industries |
| Entreprise privées | 1 |
|---|---|
Asahi Kasei Pharma Corp.
Asahi Kasei Pharma Corp. Investment ManagersFinance Part of Asahi Kasei Corp., Asahi Kasei Pharma Corp. is a pharmaceutical and diagnostic company based in Tokyo, Japan. Asahi Kasei Pharma operates in the healthcare business unit of the Asahi Kasei Group, with a mission to sincerely care for each individual life and solve their unmet medical needs with a wealth of ideas and solid science. Asahi Kasei Corp. is a US $20 billion Japanese technology company that provides innovative, science-based solutions to a diverse range of markets including healthcare, chemicals and fibers, housing and construction materials, and electronics. Founded in 2003, the private company has developed innovative drugs in the fields of orthopedics, acute care, neurology (including pain), and immunology. | Finance |
